A Genetic variant in the seed region of miR-4513 shows pleiotropic effects on lipid and glucose homeostasis, blood pressure, and coronary artery disease

Human Mutation

Volumn 35, Issue 12, 2014, Pages 1524-1531

  Ghanbari, Mohsen ^a,b   de Vries, Paul S ^a   de Looper, Hans ^c   Peters, Marjolein J ^a,d   Schurmann, Claudia ^e   Yaghootkar, Hanieh ^f   Dörr, Marcus ^e,g   Frayling, Timothy M ^f   Uitterlinden, Andre G ^a,d   Hofman, Albert ^a   van Meurs, Joyce B J ^a,d   Erkeland, Stefan J ^c   Franco, Oscar H ^a   Dehghan, Abbas ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ERASMUS MC CANCER INSTITUTE   (Netherlands)

^d Netherlands Genomics Initiative   (Netherlands)

^e UNIVERSITY MEDICINE GREIFSWALD   (Germany)

^f UNIVERSITY OF EXETER MEDICAL SCHOOL   (United Kingdom)

^g DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

Author keywords

Cardiometabolic phenotypes; MiRNA polymorphism; MiRNA seed region

Indexed keywords

GLUCOSE BLOOD LEVEL; MICRORNA; MIRN-4513 MICRORNA, HUMAN; PRIMER DNA;

BLOOD PRESSURE; CORONARY ARTERY DISEASE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETICS; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HUMAN; LIPID METABOLISM; METABOLISM; NUCLEOTIDE SEQUENCE; QUANTITATIVE TRAIT LOCUS;

BASE SEQUENCE; BLOOD GLUCOSE; BLOOD PRESSURE; CORONARY ARTERY DISEASE; DNA PRIMERS; GENOME-WIDE ASSOCIATION STUDY; HOMEOSTASIS; HUMANS; LIPID METABOLISM; MICRORNAS; POLYMORPHISM, GENETIC; QUANTITATIVE TRAIT LOCI;

EID: 84911402662     PISSN: 10597794     EISSN: 10981004     Source Type: Journal    
DOI: 10.1002/humu.22706     Document Type: Article

References (69)

1. Abelson JF, Kwan KY, O'Roak BJ, Baek DY, Stillman AA, Morgan TM, Mathews CA, Pauls DL, Rasin MR, Gunel M, Davis NR, Ercan-Sencicek AG, et al. 2005. Sequence variants in SLITRK1 are associated with Tourette's syndrome. Science 310:317-320.
2. Bao L, Zhou M, Wu L, Lu L, Goldowitz D, Williams RW, Cui Y. 2007. PolymiRTSDatabase: linking polymorphisms in microRNAtarget sites with complex traits. Nucleic Acids Res 35(Database issue):D51-D54.
3. Barenboim M, Zoltick BJ, Guo Y, Weinberger DR. 2010. MicroSNiPer: a web tool for prediction of SNPeffects on putative microRNAtargets. Hum Mutat 31:1223-1232.
4. Bartel DP. 2009. MicroRNAs: target recognition and regulatory functions. Cell 136:215-233.
5. Baskerville S, Bartel DP. 2005. Microarray profiling of microRNAs reveals frequent coexpression with neighboring miRNAs and host genes. RNA 11:241-247.
6. Bhartiya D, Laddha SV, Mukhopadhyay A, Scaria V. 2011. miRvar: A comprehensive database for genomic variations in microRNAs. Hum Mutat 32:E2226-E2245.
7. Chen L, Song J, Cui J, Hou J, Zheng X, Li C, Liu L. 2013. microRNAs regulate adipocyte differentiation. Cell Biol Int 37:533-546.
8. CARDIoGRAMplusCAD Consortium, Deloukas P, Kanoni S, Willenborg C, Farrall M, Assimes TL, Thompson JR, Ingelsson E, Saleheen D, Erdmann J, Goldstein BA, Stirrups K, et al. 2013. Large-scale association analysis identifies new risk loci for coronary artery disease. Nat Genet 45:25-33.
9. Corsten MF, Dennert R, Jochems S, Kuznetsova T, Devaux Y, Hofstra L, Wagner DR, Staessen JA, Heymans S, Schroen B. 2010. Circulating microRNA-208b and microRNA-499 reflect myocardial damage in cardiovascular disease. Circ Cardiovasc Genet 3:499-506.
10. Croce CM. 2009. Causes and consequences of microRNAdysregulation in cancer. Nat Rev Genet 10:704-714.
11. Dupuis J, Langenberg C, Prokopenko I, Saxena R, Soranzo N, Jackson AU, Wheeler E, Glazer NL, Bouatia-Naji N, Gloyn AL, Lindgren CM, Magi R, et al. 2010. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet 42:105-116.
12. Dorn GW 2nd, Matkovich SJ, Eschenbacher WH, Zhang Y. 2012. A human 3' miR-499 mutation alters cardiac mRNAtargeting and function. Circ Res 110:958-967.
13. Eulalio A, Mano M, Dal Ferro M, Zentilin L, Sinagra G, Zacchigna S, Giacca M. 2012. Functional screening identifies miRNAs inducing cardiac regeneration. Nature 492:376-381.
14. Ferreira MA, O'Donovan MC, Meng YA, Jones IR, Ruderfer DM, Jones L, Fan J, Kirov G, Perlis RH, Green EK, Smoller JW, Grozeva D, et al. 2008. Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1Cin bipolar disorder. Nat Genet 40:1056-1058.
15. Ferrucci L, Bandinelli S, Benvenuti E, Di Iorio A, Macchi C, Harris TB, Guralnik JM. 2000. Subsystems contributing to the decline in ability to walk: bridging the gap between epidemiology and geriatric practice in the InCHIANTIstudy. J Am Geriatr Soc 48:1618-1625.
16. Fichtlscherer S, Zeiher AM, Dimmeler S. 2011. Circulating microRNAs: biomarkers or mediators of cardiovascular diseases? Arterioscler Thromb Vasc Biol 31:2383-2390.
17. Friedman RC, Farh KK, Burge CB, Bartel DP. 2009. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 19:92-105.
18. Gauthier BR, Wollheim CB. 2006. MicroRNAs: 'ribo-regulators' of glucose homeostasis. Nat Med 12:36-38.
19. Global Lipids Genetics C, Willer CJ, Schmidt EM, Sengupta S, Peloso GM, Gustafsson S, Kanoni S, Ganna A, Chen J, Buchkovich ML, Mora S, Beckmann JS, et al. 2013. Discovery and refinement of loci associated with lipid levels. Nat Genet 45:1274-1283.
20. Gong J, Tong Y, Zhang HM, Wang K, Hu T, Shan G, Sun J, Guo AY. 2012. Genome-wide identification of SNPs in microRNAgenes and the SNPeffects on microRNAtarget binding and biogenesis. Hum Mutat 33:254-263.
21. Grundberg E, Small KS, Hedman AK, Nica AC, Buil A, Keildson S, Bell JT, Yang TP, Meduri E, Barrett A, Nisbett J, Sekowska M, et al. 2012. Mapping cis- and trans-regulatory effects across multiple tissues in twins. Nat Genet 44:1084-1089.
22. He L, Hannon GJ. 2004. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 5:522-531.
23. Heid IM, Jackson AU, Randall JC, Winkler TW, Qi L, Steinthorsdottir V, Thorleifsson G, Zillikens MC, Speliotes EK, Magi R, Workalemahu T, White CC, et al. 2010. Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution. Nat Genet 42:949-960.
24. Heni M, Haupt A, Schafer SA, Ketterer C, Thamer C, Machicao F, Stefan N, Staiger H, Haring HU, Fritsche A. 2010. Association of obesity risk SNPs in PCSK1 with insulin sensitivity and proinsulin conversion. BMC Med Genet 11:86.
25. Hertel JK, Johansson S, Raeder H, Platou CG, Midthjell K, Hveem K, Molven A, Njolstad PR. 2011. Evaluation of four novel genetic variants affecting hemoglobin A1c levels in a population-based type 2 diabetes cohort (the HUNT2 study). BMC Med Genet 12:20.
26. Hiard S, Charlier C, Coppieters W, Georges M, Baurain D. 2010. Patrocles: a database of polymorphic miRNA-mediated gene regulation in vertebrates. Nucleic Acids Res 38(Database issue):D640-D651.
27. Hofman A, Darwish Murad S, van Duijn CM, Franco OH, Goedegebure A, Ikram MA, Klaver CC, Nijsten TE, Peeters RP, Stricker BH, Tiemeier HW, Uitterlinden AG, Vernooji MW. 2013. The Rotterdam Study: 2014 objectives and design update. Eur J Epidemiol 28:889-926.
28. International Consortium for Blood Pressure Genome-Wide Association S, Ehret GB, Munroe PB, Rice KM, Bochud M, Johnson AD, Chasman DI, Smith AV, Tobin MD, Verwoert GC, Hwang SJ, Pihur V, et al. 2011. Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature 478:103-109.
29. International HapMap C, Frazer KA, Ballinger DG, Cox DR, Hinds DA, Stuve LL, Gibbs RA, Belmont JW, Boudreau A, Hardenbol P, Leal SM, Pasternak S, et al. 2007. A second generation human haplotype map of over 3.1 million SNPs. Nature 449:851-861.
30. Jima DD, Zhang J, Jacobs C, Richards KL, Dunphy CH, Choi WW, Au WY, Srivastava G, Czader MB, Rizzieri DA, Lagoo AS, Lugar PL, et al. 2010. Deep sequencing of the small RNAtranscriptome of normal and malignant human Bcells identifies hundreds of novel microRNAs. Blood 116:e118-e127.
31. Johnson AD, Handsaker RE, Pulit SL, Nizzari MM, O'Donnell CJ, de Bakker PI. 2008. SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap. Bioinformatics 24:2938-2939.
32. Karali M, Peluso I, Marigo V, Banfi S. 2007. Identification and characterization of microRNAs expressed in the mouse eye. Invest Ophthalmol Vis Sci 48:509-515.
33. Kawamata T, Seitz H, Tomari Y. 2009. Structural determinants of miRNAs for RISCloading and slicer-independent unwinding. Nat Struct Mol Biol 16:953-960.
34. Khvorova A, Reynolds A, Jayasena SD. 2003. Functional siRNAs and miRNAs exhibit strand bias. Cell 115:209-216.
35. Kim YK, Kim VN. 2007. Processing of intronic microRNAs. EMBO J 26:775-783.
36. Kong YW, Ferland-McCollough D, Jackson TJ, Bushell M. 2012. microRNAs in cancer management. Lancet Oncol 13:e249-e258.
37. Kornfeld JW, Baitzel C, Konner AC, Nicholls HT, Vogt MC, Herrmanns K, Scheja L, Haumaitre C, Wolf AM, Knippschild U, Seibler J, Cereghini J, et al. 2013. Obesity-induced overexpression of miR-802 impairs glucose metabolism through silencing of Hnf1b. Nature 494:111-115.
38. Kozomara A, Griffiths-Jones S. 2014. miRBase: annotating high confidence microRNAs using deep sequencing data. Nucleic Acids Res 42(Database issue):D68-D73.
39. Krol J, Sobczak K, Wilczynska U, Drath M, Jasinska A, Kaczynska D, Krzyzosiak WJ. 2004. Structural features of microRNA(miRNA) precursors and their relevance to miRNAbiogenesis and small interfering RNA/short hairpin RNAdesign. J Biol Chem 279:42230-42239.
40. Kumar M, Nath S, Prasad HK, Sharma GD, Li Y. 2012. MicroRNAs: a new ray of hope for diabetes mellitus. Protein Cell 3:726-738.
41. Lee RC, Feinbaum RL, Ambros V. 1993. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75:843-854.
42. Lin E, Pei D, Huang YJ, Hsieh CH, Wu LS. 2009. Gene-gene interactions among genetic variants from obesity candidate genes for nonobese and obese populations in type 2 diabetes. Genet Test Mol Biomarkers 13:485-493.
43. Lorenz R, Bernhart SH, Honer Zu Siederdissen C, Tafer H, Flamm C, Stadler PF, Hofacker IL. 2011. ViennaRNAPackage 2.0. Algorithms Mol Biol 6:26.
44. Manning AK, Hivert MF, Scott RA, Grimsby JL, Bouatia-Naji N, Chen H, Rybin D, Liu CT, Bielak LF, Prokopenko I, Amin N, Barnes D, Cadby G, et al. 2012. A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance. Nat Genet 44:659-669.
45. Meenhuis A, van Veelen PA, de Looper H, van Boxtel N, van den Berge IJ, Sun SM, Taskesen E, Stern P, de Ru AH, van Adrichem AJ, Demmers J, Jongen-Lavrencic M, et al. 2011. MiR-17/20/93/106 promote hematopoietic cell expansion by targeting sequestosome 1-regulated pathways in mice. Blood 118:916-925.
46. Mencia A, Modamio-Hoybjor S, Redshaw N, Morin M, Mayo-Merino F, Olavarrieta L, Aguirre LA, del Castillo I, Steel KP, Dalmay T, Moreno F, Moreno-Pelayo MA. 2009. Mutations in the seed region of human miR-96 are responsible for nonsyndromic progressive hearing loss. Nat Genet 41:609-613.
47. Mohler PJ, Rivolta I, Napolitano C, LeMaillet G, Lambert S, Priori SG, Bennett V. 2004. Nav1.5 E1053Kmutation causing Brugada syndrome blocks binding to ankyrin-Gand expression of Nav1.5 on the surface of cardiomyocytes. Proc Natl Acad Sci USA 101:17533-17538.
48. Newton-Cheh C, Johnson T, Gateva V, Tobin MD, Bochud M, Coin L, Najjar SS, Zhao JH, Heath SC, Eyheramendy S, Papadakis K, Voight BF, et al. 2009. Genome-wide association study identifies eight loci associated with blood pressure. Nat Genet 41:666-676.
49. Paterson AD, Waggott D, Boright AP, Hosseini SM, Shen E, Sylvestre MP, Wong I, Bharaj B, Cleary PA, Lachin JM; MAGIC (Meta-Analyses of Glucose and Insulin -related traits Consortium), Below JE, et al. 2010. A genome-wide association study identifies a novel major locus for glycemic control in type 1 diabetes, as measured by both A1Cand glucose. Diabetes 59:539-549.
50. Petersen CP, Bordeleau ME, Pelletier J, Sharp PA. 2006. Short RNAs repress translation after initiation in mammalian cells. Mol Cell 21:533-542.
51. Pruim RJ, Welch RP, Sanna S, Teslovich TM, Chines PS, Gliedt TP, Boehnke M, Abecasis GR, Willer CJ. 2010. LocusZoom: regional visualization of genome-wide association scan results. Bioinformatics 26:2336-2337.
52. Richardson K, Nettleton JA, Rotllan N, Tanaka T, Smith CE, Lai CQ, Parnell LD, Lee YC, Lahti J, Lemaitre RN, Manichaikul A, Keller M, et al. 2013. Gain-of-function lipoprotein lipase variant rs13702 modulates lipid traits through disruption of a microRNA-410 seed site. Am J Hum Genet 92:5-14.
53. Saunders MA, Liang H, Li WH. 2007. Human polymorphism at microRNAs and microRNAtarget sites. Proc Natl Acad Sci USA 104:3300-3305.
54. Saxena R, Hivert MF, Langenberg C, Tanaka T, Pankow JS, Vollenweider P, Lyssenko V, Bouatia-Naji N, Dupuis J, Jackson AU, Kao WH, Li M, et al. 2010. Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge. Nat Genet 42: 142-148.
55. Scott RA, Lagou V, Welch RP, Wheeler E, Montasser ME, Luan J, Magi R, Strawbridge RJ, Rehnberg E, Gustafsson S, Kanoni S, Rasmussen-Torvik LJ, et al. 2012. Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways. Nat Genet 44:991-1005.
56. Shu J, Xia Z, Li L, Liang ET, Slipek N, Shen D, Foo J, Subramanian S, Steer CJ. 2012. Dose-dependent differential mRNAtarget selection and regulation by let-7a-7f and miR-17-92 cluster microRNAs. RNA Biol 9:1275-1287.
57. Song DW, Ryu JY, Kim JO, Kwon EJ, Kim DH. 2013. MicroRNA-19a/b family positively regulates cardiomyocyte hypertrophy by targeting atrogin-1 and MuRF-1. Biochem J 457:151-162.
58. Speliotes EK, Willer CJ, Berndt SI, Monda KL, Thorleifsson G, Jackson AU, Lango Allen H, Lindgren CM, Luan J, Magi R, Randall JC, Vedantam S, et al. 2010. Association analyses of 249796 individuals reveal 18 new loci associated with body mass index. Nat Genet 42:937-948.
59. Stather PW, Sylvius N, Wild JB, Choke E, Sayers RD, Bown MJ. 2013. Differential microRNAexpression profiles in peripheral arterial disease. Circ Cardiovasc Genet 6:490-497.
60. Teslovich TM, Musunuru K, Smith AV, Edmondson AC, Stylianou IM, Koseki M, Pirruccello JP, Ripatti S, Chasman DI, Willer CJ, Johansen CT, Fouchier SW, et al. 2010. Biological, clinical and population relevance of 95 loci for blood lipids. Nature 466:707-713.
61. Trajkovski M, Hausser J, Soutschek J, Bhat B, Akin A, Zavolan M, Heim MH, Stoffel M. 2011. MicroRNAs 103 and 107 regulate insulin sensitivity. Nature 474:649-653.
62. Tsang J, Zhu J, van Oudenaarden A. 2007. MicroRNA-mediated feedback and feedforward loops are recurrent network motifs in mammals. Mol Cell 26:753-767.
63. van Rooij E, Olson EN. 2012. MicroRNAtherapeutics for cardiovascular disease: opportunities and obstacles. Nat Rev Drug Discov 11:860-872.
64. Volzke H, Alte D, Schmidt CO, Radke D, Lorbeer R, Friedrich N, Aumann N, Lau K, Piontek M, Born G, Havemann C, Ittermann T, et al. 2011. Cohort profile: the study of health in Pomerania. Int J Epidemiol 40:294-307.
65. Wain LV, Verwoert GC, O'Reilly PF, Shi G, Johnson T, Johnson AD, Bochud M, Rice KM, Henneman P, Smith AV, Ehret GB, Amin N, et al. 2011. Genome-wide association study identifies six new loci influencing pulse pressure and mean arterial pressure. Nat Genet 43:1005-1011.
66. Walker DM, Urbe S, Dove SK, Tenza D, Raposo G, Clague MJ. 2001. Characterization of MTMR3. an inositol lipid 3-phosphatase with novel substrate specificity. Curr Biol 11:1600-1605.
67. Wang J, Wang Q, Liu H, Shao N, Tan B, Zhang G, Wang K, Jia Y, Ma W, Wang N, Cheng Y. 2012. The association of miR-146a rs2910164 and miR-196a2 rs11614913 polymorphisms with cancer risk: a meta-analysis of 32 studies. Mutagenesis 27:779-788.
68. Westra HJ, Peters MJ, Esko T, Yaghootkar H, Schurmann C, Kettunen J, Christiansen MW, Fairfax BP, Schramm K, Powell JE, Zhernakova A, Zhernakova DV, et al. 2013. Systematic identification of trans eQTLs as putative drivers of known disease associations. Nat Genet 45:1238-1243.
69. Zhao X, Ye Q, Xu K, Cheng J, Gao Y, Li Q, Du J, Shi H, Zhou L. 2013. Single-nucleotide polymorphisms inside microRNAtarget sites influence the susceptibility to type 2 diabetes. J Hum Genet 58:135-141.